COMMODORE CAPITAL LP logo

COMMODORE CAPITAL LP Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for COMMODORE CAPITAL LP with $2.0B in long positions as of Q3 2025, 93% allocated to Healthcare, and 59% concentrated in top 10 positions.

Portfolio Value
$2.0B
Top 10 Concentration
59%
Top Sector
Healthcare (93%)
US Exposure
68%
Market Cap Focus
Mid Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 93.20%Healthcare
Healthcare
93.20%

Industry Breakdown

1 industry across all sectors

Biotechnology: 93.18%Biotechnology
Biotechnology
Healthcare
93.18%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 54.75%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 38.08%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 3.37%Nano Cap (< $50M): 0.43%N/A (ETF or Unknown): 3.37%
Mid Cap ($2B - $10B)
54.75%
Small Cap ($300M - $2B)
38.08%
Micro Cap ($50M - $300M)
3.37%
Nano Cap (< $50M)
0.43%
N/A (ETF or Unknown)
3.37%

Portfolio Concentration

Top 10 Holdings %
58.91%
Top 20 Holdings %
85.68%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
67.69%
International
32.31%
Countries
4
Largest Int'l Market
Netherlands - 19.15%
United States of America
67.69% ($1.4B)
31 holdings
Netherlands
19.15% ($392.2M)
2 holdings
Canada
8.63% ($176.8M)
3 holdings
Ireland
4.54% ($92.9M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
11 quarters
Avg. Top 20
7.5 quarters
Avg. All Positions
5.4 quarters
Median Holding Period
4 quarters
Persistence Rate
51.35%
Persistent Holdings Weight
68.04%
Persistent Positions
19
Longest Held
Cogent Biosciences, Inc. Common Stock logo
Cogent Biosciences, Inc. Common StockCOGT - 19 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
1.41%
Avg. Position Weight
2.70%
Largest Position
Merus N.V. Common Shares logo
Merus N.V. Common SharesMRUS - 16.20%
Largest Ownership Stake
SAB Biotherapeutics, Inc. Common Stock logo
SAB Biotherapeutics, Inc. Common StockSABS - 42.28%
Avg. Ownership Stake
4.44%
Ownership Stake >5%
12
Ownership Stake >1%
35

Historical (Since Q4 2020)

Avg. New Position
3.04%
Avg. Ownership Stake
3.97%
Largest Position
Merus N.V. Common Shares logo
Merus N.V. Common SharesMRUS - 16.78% (Q2 2022)
Largest Ownership Stake
SAB Biotherapeutics, Inc. Common Stock logo
SAB Biotherapeutics, Inc. Common StockSABS - 42.28% (Q3 2025)

Portfolio Turnover

Current Quarter

Turnover Ratio
14.4%
Value Traded
$295.86M
Positions Added
4
Positions Exited
3

Historical (Since Q4 2020)

Avg. Turnover Ratio
20.9%
Avg. Positions Added
6
Avg. Positions Exited
5
Highest Turnover
50.0%
Q4 2020
Lowest Turnover
12.8%
Q3 2024

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.